Preferred Label : carcinoma, renal cell;
MeSH definition : A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the
KIDNEYS. There are several subtypes including the clear cells, the papillary, the
chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type
carcinoma.;
MeSH synonym : nephroid carcinomas; renal cell carcinoma; renal cell adenocarcinomas; adenocarcinoma, renal cell; carcinoma, nephroid; carcinomas, renal cell; renal cell carcinomas; renal cell adenocarcinoma; nephroid carcinoma; adenocarcinomas, renal cell; renal cell cancer; cancer, renal cell; renal cell cancers; adenocarcinoma of kidney; adenocarcinoma, renal; Adenocarcinoma Of Kidneys; Kidney, Adenocarcinoma Of; Renal Adenocarcinoma; Renal Adenocarcinomas; Renal Carcinoma; Carcinoma, Renal; Renal Carcinomas;
CISMeF synonym : sacromatoid renal cell carcinoma; duct carcinoma, collecting (Kidney); duct carcinomas, collecting (Kidney); duct carcinoma, collecting; duct carcinomas, collecting; Adenocarcinomas, Renal; Kidneys, Adenocarcinoma Of; cancers, renal cell; carcinomas, nephroid;
MeSH hyponym : collecting duct carcinoma (Kidney); chromophobe renal cell carcinoma; sarcomatoid renal cell carcinoma; clear cell renal cell carcinoma; papillary renal cell carcinoma; Renal Cell Carcinoma, Papillary; Chromophil Renal Cell Carcinoma; Grawitz Tumor; Tumor, Grawitz; Clear Cell Renal Carcinoma; Carcinoma, Hypernephroid; Carcinomas, Hypernephroid; Hypernephroid Carcinoma; Hypernephroid Carcinomas; Hypernephroma; Hypernephromas; Carcinoma, Collecting Duct (Kidney); Carcinomas, Collecting Duct (Kidney); Collecting Duct Carcinomas (Kidney); Collecting Duct Carcinoma of the Kidney; Renal Collecting Duct Carcinoma; Collecting Duct Carcinoma; Carcinoma, Collecting Duct; Carcinomas, Collecting Duct; Collecting Duct Carcinomas;
MeSH annotation : coordinate IM with KIDNEY NEOPLASMS (IM);
Wikipedia link : https://en.wikipedia.org/wiki/Carcinoma, renal cell;
Origin ID : D002292;
UMLS CUI : C0007134;
Allowable qualifiers
- Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- DO Cross reference
- False automatic mappings
- HPO term
- Indexing information
- Manual NTBT mappings (CISMeF)
- MedlinePlus topic(s)
- ORDO relation(s)
- Record concept(s)
- Related MeSH Supplementary Concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the
KIDNEYS. There are several subtypes including the clear cells, the papillary, the
chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type
carcinoma.
https://www.cochrane.org/fr/CD013798/PROSTATE_traitement-initial-chez-les-adultes-atteints-dun-cancer-du-rein-avance-carcinome-cellules-renales
2023
United Kingdom
review of literature
french abstract
adulthood
cancer of kidney
Kidney cancer
Kidney
Cell
Carcinoma
carcinoma
neoplasm, malignant
malignant neoplasm of kidney
Adult
adult
kidney, nos
disease
cells
Adult
"u" lymphocyte
carcinoma, renal cell
---
https://www.has-sante.fr/jcms/p_3294121/fr/cabometyx-20-40-mg-cabozantinib-carcinome-a-cellules-renales-avance-en-association-au-nivolumab
2021
false
false
false
France
evaluation of the transparency committee
cells
carcinoma
nivolumab
Nivolumab
kidney, nos
"u" lymphocyte
traction
Cell
indication of
carcinoma, renal cell
association
indicators
cabozantinib
Carcinoma
indicators and reagents
---
https://www.has-sante.fr/jcms/p_3297501/fr/opdivo-10-mg/ml-nivolumab-carcinome-a-cellules-renales-avance-en-association-cabozantinib
2021
France
evaluation of the transparency committee
carcinoma
Cell
Carcinoma
kidney, nos
Opdivo
"u" lymphocyte
cells
nivolumab
association
carcinoma, renal cell
Nivolumab
cabozantinib
---
https://www.has-sante.fr/jcms/p_3184677/fr/keytruda-cancer-du-rein
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
carcinoma, renal cell
antineoplastic combined chemotherapy protocols
Axitinib
Antineoplastic Agents, Immunological
pembrolizumab
infusions, intravenous
survival analysis
evaluation of the transparency committee
pembrolizumab
antibodies, monoclonal, humanized
antibodies, monoclonal
antibodies, monoclonal, humanized
---
https://www.sfed.org/sites/www.sfed.org/files/2021-10/ksuperfdig_colon.pdf
2018
false
false
false
France
French
guideline
superficial
large intestine, nos
Colon cancer
recommendations, health planning
directive counseling
cancer of colon
colon
gastrointestinal tract
tube, nos
colorectal neoplasms
neoplasm, malignant
digestant, nos
Digestive tract
digestive system, nos
carcinoma, renal cell
health planning guidelines
colonic neoplasms
gastrointestinal tract
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=FR&Expert=319287
2017
false
false
false
France
French
scientific and technical information
carcinoma, renal cell
kidney, nos
carcinoma
cystic
multiloculated
carcinoma
---
https://dumas.ccsd.cnrs.fr/dumas-01664323
2017
false
false
false
France
French
dissertations, academic
screening for cancer
cancer screening
malignant neoplasm colon/rectum
immunologic
feces
immunologic tests
occult blood
has patient
colorectal neoplasms
carcinoma, renal cell
faeces test
patient participation
early detection of cancer
---
http://kce.fgov.be/fr/publication/report/cancer-du-rein-chez-l%E2%80%99adulte-diagnostic-traitement-et-suivi
https://kce.fgov.be/sites/default/files/2021-11/KCE_253B_Cancer_du_rein_Resume.pdf
2015
false
false
true
Belgium
French
practice guideline
french abstract
carcinoma, renal cell
carcinoma, renal cell
carcinoma, renal cell
carcinoma, renal cell
carcinoma, renal cell
Positron-Emission tomography
tomography, X-ray computed
carcinoma, renal cell
PET-CT
neoplasm metastasis
neoplasm recurrence, local
carcinoma, renal cell
nephrectomy
catheter ablation
cryosurgery
treatment outcome
molecular targeted therapy
adult
antineoplastic agents
antineoplastic agents
watchful waiting
carcinoma, renal cell
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=FR&Expert=404514
2014
false
true
false
France
French
scientific and technical information
carcinoma
kidney disease, nos
acquired disease, nos
carcinoma, renal cell
associated with
disease
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=FR&Expert=319276
2014
false
false
false
France
French
scientific and technical information
kidney, nos
carcinoma, renal cell
clear cell adenocarcinoma, nos
cells
carcinoma
cells
carcinoma
---
Summary Basis of Decision (SBD) for Inlyta
Axitinib, 1 mg and 5 mg, Tablet, Oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00071
2012
false
Canada
French
English
clear-cell metastatic renal cell carcinoma
drug information
Axitinib 1mg tablet (product)
Axitinib 5mg tablet (product)
Tyrosine Kinase Inhibitors
drug approval
canada
administration, oral
axitinib
neoplasm metastasis
protein kinase inhibitors
protein kinase inhibitors
carcinoma, renal cell
vascular endothelial growth factor receptor-1
vascular endothelial growth factor receptor-2
vascular endothelial growth factor receptor-3
drug evaluation, preclinical
treatment outcome
clinical trials, phase iii as topic
risk assessment
Axitinib
Axitinib
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=247203
2011
France
scientific and technical information
carcinoma, renal cell
---
http://www.msss.gouv.qc.ca/sujets/organisation/lutte-contre-le-cancer/documents/guides-cepo-pdf/CEPO-Guide_utilisation_Sorafenib_cancer_du_rein_m%C3%A9tastatique_(2010-11-15).pdf
2010
false
false
Canada
French
phenylurea compounds
niacinamide
carcinoma, renal cell
neoplasm metastasis
Evidence-Based medicine
receptors, vascular endothelial growth factor
raf kinases
treatment outcome
antineoplastic combined chemotherapy protocols
survival analysis
quality of life
sorafenib
benzenesulfonates
pyridines
antineoplastic agents
protein kinase inhibitors
sorafenib tosylate
guidelines for drug use
Sorafenib
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=FR&Expert=422526
2010
false
true
false
France
French
scientific and technical information
carcinoma, renal cell
clear cell adenocarcinoma, nos
carcinoma
---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/48/A2/resume.phtml?type=text.html
2009
France
French
arthrography
carcinoma, renal cell
kidney neoplasms
prognosis
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=47044
2007
true
France
English
French
resource guides
scientific and technical information
rare diseases
Papillary renal cell carcinoma, familial
carcinoma, renal cell
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=151
2007
France
French
English
resource guides
scientific and technical information
carcinoma, renal cell
familial renal cell carcinoma
rare diseases
---
http://www.msss.gouv.qc.ca/sujets/organisation/lutte-contre-le-cancer/documents/guides-cepo-pdf/avis_capecitabine_cellules_renales.pdf
2004
false
false
Canada
French
Capecitabine
antimetabolites, antineoplastic
kidney neoplasms
carcinoma, renal cell
antineoplastic combined chemotherapy protocols
treatment outcome
neoplasm metastasis
capecitabine
guidelines for drug use
---
http://www.urofrance.org/fileadmin/documents/data/PU/2004/PU-2004-00140997-4-1/TEXF-PU-2004-00140997-4-1.PDF
2004
France
French
kidney neoplasms
kidney neoplasms
signs and symptoms
kidney neoplasms
prognosis
risk factors
kidney neoplasms
nephrectomy
france
kidney neoplasms
kidney neoplasms
prevalence
incidence
renal insufficiency
mass screening
kidney neoplasms
kidney neoplasms
tomography, X-ray computed
kidney neoplasms
genetic predisposition to disease
carcinoma, renal cell
von Hippel-Lindau disease
von Hippel-Lindau disease
von Hippel-Lindau disease
von Hippel-Lindau disease
von Hippel-Lindau disease
age distribution
von Hippel-Lindau disease
biopsy, needle
carcinoma, papillary
neoplasm staging
nephrectomy
nephrectomy
neoplasm metastasis
kidney neoplasms
neoplasm metastasis
kidney transplantation
adult
aged
mass screening
kidney neoplasms
genetic testing
magnetic resonance imaging
biopsy, needle
Minimally Invasive Surgical Procedures
adrenalectomy
adrenal gland neoplasms
lymph node excision
neoplastic cells, circulating
survival rate
laparoscopy
laparoscopy
neoplasm recurrence, local
Evidence-Based medicine
practice guideline
kidney neoplasms
von Hippel-Lindau disease
---
